As of Aug 31
| +0.04 / +0.23%|
The 6 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 23.00, with a high estimate of 29.00 and a low estimate of 15.00. The median estimate represents a +32.41% increase from the last price of 17.37.
The current consensus among 8 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.